FindTrial
Sign In

Can Amrita Bhallataka Paka help boost immunity? A study using healthy human blood sample.

Screening of free radical scavenging activity and immunomodulatory effect of Amrita Bhallataka Paka - An experimental study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/03/105828
Enrollment
6
Registered
2026-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil Intervention5: Nil: Nil Intervention6: Nil: Nil Intervention7: Nil: Nil

Sponsors

Dr Akansha G Puppalwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy adult humans blood will be collected.

Exclusion criteria

Exclusion criteria: 1) Metabolic disorders like Diabetes mellitus, hypertenstion, immune disorders,etc. 2)Subjects in the convalescent phase of any infection. 3)Subjects who are on any medications.

Design outcomes

Primary

MeasureTime frame
Amrita Bhallataka paka will show free radical scavenging and immuno-modulatory effectTimepoint: Baseline only—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Prashant G Jadar
drjadar@yahoo.co.in9448301308

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026